Burning Bush Allergy: Which Plant? Kochia Pollen, Symptoms & Treatment
Burning bush allergy means kochia weed pollen (Bassia scoparia) โ not the ornamental shrub. The ornamental burning bush (Euonymus alatus) is an entirely different, insect-pollinated shrub that is not a significant allergen. Kochia has research-characterized allergens Koc s 1 and Koc s 2 and cross-reacts extensively within the Amaranthaceae family. Treatment includes avoidance, pharmacotherapy, and sublingual immunotherapy for weed pollen desensitization.
Free ยท 5 min ยท Insurance accepted
Key facts
Kochia (Bassia scoparia) pollen season runs July through October, peaking in AugustโSeptember and coinciding with ragweed and mugwort in the Great Plains.
Koc s 1 is an Ole e 1-like protein sharing structural homology with Che a 1 (lambsquarters), explaining cross-reactivity within the Amaranthaceae family at the extract level.
Herbicide-resistant kochia populations have been confirmed in over 30 US states since glyphosate resistance was first documented in Kansas in 2007, expanding regional pollen loads.
Larenas-Linnemann D et al., Ann Allergy Asthma Immunol, 2020
Ornamental Euonymus alatus (winged euonymus) is insect-pollinated and in the Celastraceae family โ it is entirely unrelated to allergenic kochia and is not a significant allergen source.
Patients with kochia allergy typically react to lambsquarters, Russian thistle, and pigweed via shared Amaranthaceae family epitopes, often requiring multi-allergen immunotherapy for the full fall weed burden.
What Is Burning Bush Allergy?
Burning bush allergy requires an immediate disambiguation: the name "burning bush" refers to two completely unrelated plants with entirely different allergy profiles.
The allergenically significant burning bush is Bassia scoparia (formerly Kochia scoparia), a wind-pollinated annual weed in the Amaranthaceae family that is a major fall aeroallergen across the central and western United States. The other burning bush โ Euonymus alatus (winged euonymus) โ is an insect-pollinated ornamental shrub in the Celastraceae family, widely planted for its red fall foliage but not a significant allergen.
This page focuses on Bassia scoparia, the allergenic weed. Known as kochia, summer cypress, or Mexican fireweed, this fast-growing annual thrives in disturbed soils, agricultural fields, roadsides, and rangelands throughout the Great Plains and Intermountain West. It is wind-pollinated and produces copious pollen from July through October.
Kochia has two research-characterized allergens: Koc s 1, an Ole e 1-like protein that shares structural homology with Che a 1 (lambsquarters) and Ole e 1 (olive), and Koc s 2, a profilin. Neither has been formally listed by WHO/IUIS yet, representing a gap between research characterization and official allergen database inclusion.
The naming confusion between Bassia scoparia and Euonymus alatus creates genuine clinical miscommunication. Patients who report burning bush allergy to their allergist may be describing symptoms triggered by the weedy kochia in agricultural fields, or they may be pointing to the ornamental shrub in their front yard. Clarifying which plant the patient means is the essential first step in any clinical encounter. Kochia is identifiable as a fast-growing, densely branched annual herb with narrow, lance-shaped leaves and a bushy, rounded form that turns brilliant red or purple in autumn โ earning the names burning bush, Mexican fireweed, and summer cypress. Euonymus alatus is a slow-growing deciduous shrub with corky, wing-like bark ridges on its branches and brilliant crimson fall foliage. The two plants could not be more different in appearance, yet the shared common name persists in popular usage.
Burning Bush (Kochia) Allergy Symptoms
Recognizing symptoms early helps you get the right treatment faster.
Nasal congestion
moderateBilateral nasal obstruction from mucosal swelling that worsens during outdoor exposure in kochia-dense areas, particularly on windy days.
Sneezing and rhinorrhea
mildRepetitive sneezing with watery nasal discharge triggered by pollen inhalation, often most prominent in the morning and during outdoor activities.
Allergic conjunctivitis
moderateRed, itchy, watery eyes with lid swelling that develops within minutes of outdoor pollen exposure during peak kochia season.
Asthma exacerbation
severeWheezing, chest tightness, and shortness of breath in kochia-sensitized patients with allergic asthma, particularly during high-count days.
Post-nasal drip cough
mildPersistent cough from mucus draining into the pharynx, often worse when lying down and disrupting sleep quality.
Palatal itching
mildItching of the soft palate and ear canals, a characteristic feature of pollen-driven allergic rhinitis caused by shared sensory nerve pathways.
Fatigue and impaired concentration
moderateChronic nasal congestion and disrupted sleep from nighttime symptoms contribute to significant daytime fatigue and cognitive impairment.
When to see a doctor
Kochia pollen allergy produces the full spectrum of IgE-mediated respiratory symptoms. Because kochia often co-occurs with Russian thistle, ragweed, and mugwort in the same geographic regions and during the same season, patients may experience particularly severe composite symptoms from multiple simultaneous pollen exposures. Patients with pre-existing asthma should be vigilant during the July-October pollen season, as kochia and other Amaranthaceae weed pollens are associated with asthma exacerbations in sensitized individuals. If you experience progressive chest tightness, wheezing that does not respond to your rescue inhaler, or difficulty breathing during fall pollen season, seek emergency care. The fatigue and cognitive impairment associated with chronic nasal congestion during the four-month kochia pollen season significantly impacts quality of life beyond the obvious nasal and ocular symptoms. Studies of allergic rhinitis patients consistently show that sleep disruption from nighttime congestion reduces cognitive performance, reaction times, and academic or workplace productivity to a degree comparable to mild-to-moderate sleep deprivation. Patients who describe their fall allergy burden as merely annoying may be underestimating its impact on daily functioning. Objective sleep quality measures and daytime sleepiness scales can help quantify this burden and support the case for escalating treatment to disease-modifying immunotherapy rather than relying solely on symptomatic relief.
Can Kochia Pollen Trigger Asthma?
Kochia pollen is associated with allergic asthma in sensitized individuals, particularly in the Great Plains and western US where Amaranthaceae weed pollen concentrations can be substantial. The asthma risk is compounded by the co-occurrence of kochia with Russian thistle โ a weed specifically associated with severe disabling asthma โ during the same fall pollen season. Patients with kochia sensitization and pre-existing asthma should optimize their controller medications before the fall pollen season begins, have a current asthma action plan, and ensure rescue medications are readily available. If fall is consistently your worst asthma season and you live in a region with abundant kochia, discuss specific Amaranthaceae weed pollen testing with your allergist.
Complications of Untreated Kochia Allergy
Untreated kochia pollen allergy follows the same complication trajectory as other chronic aeroallergen sensitivities: persistent nasal inflammation can progress to chronic rhinosinusitis, and ongoing lower airway inflammation may worsen asthma control. The Amaranthaceae cross-reactivity pattern means that patients who remain untreated may develop progressively broader sensitization to related weeds, compounding their fall symptom burden. The emerging herbicide resistance of kochia populations is a public health concern: as resistant kochia spreads into previously unaffected agricultural regions, new populations may be exposed and sensitized.
Chronic rhinosinusitis
Repeated seasonal nasal inflammation from kochia and co-occurring Amaranthaceae pollens may lead to chronic sinus disease requiring medical or surgical intervention.
Worsening asthma control
Annual fall pollen exposure without adequate treatment can progressively worsen asthma through repeated airway inflammation and structural remodeling.
Expanding polysensitization
Without disease-modifying immunotherapy, the inflammatory cascade may promote sensitization to additional aeroallergens beyond the initial Amaranthaceae triggers.
Quality-of-life impairment
Months of nasal congestion, poor sleep, and reduced exercise tolerance significantly impact work productivity, academic performance, and overall well-being.
What Causes Burning Bush (Kochia) Allergy?
Kochia pollen allergy develops through standard IgE-mediated sensitization. Bassia scoparia is dioecious and wind-pollinated, releasing lightweight pollen grains from July through October. In the Great Plains and Intermountain West, kochia can form dense stands along roadsides, in fallow agricultural fields, and on disturbed ground, producing substantial local pollen concentrations during peak season.
Kochia / burning bush / summer cypress
Bassia scoparia
Ornamental kochia (turns red in fall)
Bassia scoparia f. trichophylla
Winged euonymus / ornamental burning bush (NOT allergenic)
Euonymus alatus
How it works
Kochia pollen proteins, including Koc s 1 (Ole e 1-like) and Koc s 2 (profilin), are inhaled and penetrate the nasal and bronchial mucosa. Antigen-presenting cells process these proteins and activate Th2 lymphocytes, which drive B cell class-switching to produce allergen-specific IgE. The IgE binds to mast cells in respiratory tissues. Upon re-exposure, pollen proteins cross-link surface IgE, triggering mast cell degranulation with histamine, leukotriene, and prostaglandin release โ producing the immediate symptoms of allergic rhinoconjunctivitis.
The extensive cross-reactivity within the Amaranthaceae family means that patients sensitized to kochia frequently also react to lambsquarters (Chenopodium album), Russian thistle (Salsola kali), pigweed (Amaranthus), and saltbush (Atriplex) at the extract level. Shared profilins and polcalcins drive much of this cross-reactivity. However, unlike Russian thistle's unique Sal k 1 (which has no Chenopodium homolog), kochia's Koc s 1 shares structural homology with Che a 1 โ meaning that co-positivity between kochia and lambsquarters testing may reflect genuine structural cross-reactivity rather than independent dual sensitization.
Kochia is also an emerging herbicide-resistant agricultural weed, with resistance to glyphosate, ALS inhibitors, and dicamba documented in over 30 US states. This resistance is driving population expansion, increasing human exposure to kochia pollen in agricultural regions.
Kochia's herbicide resistance pattern is accelerating its spread across US agricultural landscapes. Documented resistance to glyphosate (first confirmed in Kansas in 2007), ALS-inhibiting herbicides, and most recently to dicamba has made kochia increasingly difficult to control in crop production systems. This resistance-driven population expansion means more kochia plants in more locations, producing more pollen over a larger geographic area. Some agricultural counties in Kansas and Colorado report kochia densities exceeding 100 plants per square meter in untreated field margins. For allergy patients in these regions, the practical consequence is steadily increasing ambient pollen exposure during the July through October season, even in areas where kochia was previously uncommon.
Risk factors to watch for
Residence in the Great Plains or Intermountain West
Kochia is most abundant in Kansas, Nebraska, Colorado, Montana, and the Dakotas, where agricultural land and disturbed ground provide ideal habitat.
Agricultural occupations
Farmers and ranchers in kochia-infested regions face elevated pollen exposure during harvest season, particularly as herbicide-resistant kochia populations expand.
Co-sensitization to Amaranthaceae weeds
Patients already sensitized to lambsquarters, Russian thistle, or pigweed may have heightened susceptibility to kochia sensitization through shared family-level allergen homology.
Atopic predisposition
Individuals with existing IgE-mediated allergies to other pollens, dust mites, or mold are at higher risk of developing additional aeroallergen sensitizations including kochia.
The Allergy Cascade
Exposure
Allergen contact
Detection
Immune recognition
IgE Response
Antibody production
Mast Cells
Histamine release
Symptoms
Allergic reaction
1.Exposure
Allergen contact
2.Detection
Immune recognition
3.IgE Response
Antibody production
4.Mast Cells
Histamine release
5.Symptoms
Allergic reaction
Diagnosing Kochia (Burning Bush) Allergy
Diagnosing kochia allergy requires specific IgE testing through skin prick or serum-based assays. ImmunoCAP testing for the broader Chenopodium/Amaranthaceae family is available through standard allergy laboratories, though kochia-specific component testing (Koc s 1, Koc s 2) is limited to specialized research centers. The diagnostic challenge lies in parsing the extensive Amaranthaceae cross-reactivity. A patient testing positive to both Chenopodium and Bassia extracts may have primary sensitization to one and cross-reactivity to the other, or may be genuinely co-sensitized to both. Because Koc s 1 and Che a 1 share Ole e 1-like structural homology, distinguishing primary from cross-reactive sensitization requires molecular-level component testing that is not yet widely available. At-home allergy testing services like Curex provide comprehensive panels covering 40+ common environmental allergens including weed pollens, with results typically within 5 days and insurance coverage. Identifying the full scope of fall weed pollen sensitizations is critical for optimizing immunotherapy formulation. Component-resolved diagnostics represent the frontier of distinguishing primary kochia sensitization from cross-reactive Amaranthaceae positivity. Koc s 1, the Ole e 1-like protein, shares structural homology with Che a 1 from Chenopodium album, meaning that extract-level testing cannot definitively determine whether a patient reacting to both is truly co-sensitized or merely cross-reacting through shared epitopes. As molecular allergy testing becomes more widely available, Koc s 1-specific IgE measurement will allow clinicians to identify patients with genuine primary kochia sensitization who would benefit from kochia-specific immunotherapy formulation. Until then, clinical correlation with geographic exposure and symptom patterns provides the best guidance for immunotherapy decisions.
Skin Prick Test with Amaranthaceae Extracts
Standardized pollen extracts for Chenopodium/Amaranthaceae are applied via skin prick. A positive result indicates IgE sensitization to the family but does not distinguish kochia from lambsquarters or other family members.
Serum Specific IgE (ImmunoCAP)
Blood-based measurement of IgE to Chenopodium/Amaranthaceae pollen extracts. Quantitative results can be compared across species to suggest primary sensitization patterns.
Comprehensive Environmental Allergen Panel
Broad IgE panel testing for weed, grass, and tree pollens, mold, and indoor allergens to map the full sensitization profile and identify all treatment targets for immunotherapy.
Test from home with Curex
Skip the clinic visit. Curex sends an at-home allergy test kit to your door, and a board-certified allergist reviews your results to build a personalized treatment plan.
Take the allergy quizTreating Burning Bush (Kochia) Allergy
See how different approaches stack up for managing your allergy symptoms long-term.
Treatment of kochia allergy follows the same stepwise approach as other fall weed pollen allergies: avoidance, pharmacotherapy, and immunotherapy. Because kochia is abundant across the Great Plains and western US and co-occurs with multiple other Amaranthaceae pollen sources, immunotherapy addressing the entire fall weed pollen sensitization profile provides the most comprehensive long-term benefit.
For patients with kochia-associated asthma, optimizing controller medications before the fall season is essential. The pharmacotherapy approach should be guided by symptom severity and the presence or absence of lower airway involvement.
Allergen Avoidance
Monitor fall weed pollen counts from July through October. Keep windows closed, use HEPA air purifiers, and shower after outdoor activities during peak pollen periods. Remove ornamental kochia plants from your property if present.
N/A
Reduces exposure but is challenging in regions where kochia is ubiquitous; supplemental to pharmacotherapy
Oral Antihistamines
Second-generation antihistamines for mild-to-moderate rhinoconjunctivitis symptoms. Effective for sneezing, rhinorrhea, and ocular itch; less effective for nasal congestion.
Cetirizine (Zyrtec), loratadine (Claritin), fexofenadine (Allegra)
Studies suggest 40-60% symptom reduction for rhinitis; combine with nasal corticosteroids for better control
Intranasal Corticosteroids
First-line treatment for moderate-to-severe allergic rhinitis. Addresses nasal congestion, rhinorrhea, sneezing, and itching through local anti-inflammatory action.
Fluticasone propionate (Flonase), mometasone (Nasonex), budesonide (Rhinocort)
Superior to antihistamines for nasal symptoms in clinical trials; begin 1-2 weeks before season for optimal effect
Subcutaneous Immunotherapy (SCIT)
Traditional allergy shots containing Amaranthaceae weed pollen extracts and other identified allergens. Provides long-term disease modification through immune tolerance induction.
Custom-formulated allergen extracts
Evidence demonstrates 60-80% symptom reduction over 3-5 years with sustained benefit
Sublingual Immunotherapy (SLIT)
At-home allergen drops targeting kochia and other confirmed fall weed pollen sensitizations. Custom-formulated to match individual allergy profiles.
Custom sublingual allergen drops
Clinical trials show 60-85% symptom reduction for weed pollen desensitization; disease modification sustained after treatment completion
| Feature | Traditional | Allergy Shots (SCIT) | Immunotherapy (SLIT)Recommended |
|---|---|---|---|
| Treats root cause | No | Yes | Yes |
| Long-lasting relief | No | Yes | Yes |
| At-home treatment | Yes | No | Yes |
| No office visits | Yes | No | Yes |
| Low side effects | Yes | Partial | Yes |
| Estimated cost | Partial | Partial | Yes |
Traditional
- NoTreats root cause
- NoLong-lasting relief
- YesAt-home treatment
- YesNo office visits
- YesLow side effects
- PartialEstimated cost
Allergy Shots (SCIT)
- YesTreats root cause
- YesLong-lasting relief
- NoAt-home treatment
- NoNo office visits
- PartialLow side effects
- PartialEstimated cost
Immunotherapy (SLIT)
Recommended- YesTreats root cause
- YesLong-lasting relief
- YesAt-home treatment
- YesNo office visits
- YesLow side effects
- YesEstimated cost
Immunotherapy for Kochia and Fall Weed Pollen
Instead of masking symptoms, immunotherapy retrains your immune system.
Allergen immunotherapy is the most effective long-term strategy for kochia-sensitized patients, particularly those who also react to other Amaranthaceae weeds, ragweed, and mugwort. Because fall weed pollen avoidance is extremely difficult in the Great Plains and western US, immunotherapy addresses the root cause of the disease โ the immune system's disproportionate IgE response to pollen proteins. Both subcutaneous (SCIT) and sublingual (SLIT) immunotherapy are effective for weed pollen desensitization. SCIT requires weekly in-clinic injections during the build-up phase, while SLIT drops are administered at home daily, eliminating the clinic visit burden. Sublingual immunotherapy, offered by providers like Curex, delivers custom-formulated allergen drops targeting your specific fall weed pollen sensitization profile. Plans have program-specific pricing (https://getcurex.com/learn/curex-pricing); insurance billing for testing and consultations depends on your plan; insurance accepted for testing and consultations. In a real-world Curex study of 2,897 patients on at-home sublingual immunotherapy, peer-reviewed in Frontiers in Allergy, clinically meaningful symptom improvement rose to 45% of patients by two years, with quality-of-life improvement reaching 90.7% and adherence over 90%. For patients in kochia-endemic regions facing months of combined Amaranthaceae, ragweed, and mugwort pollen exposure each fall, multiallergen SLIT can meaningfully transform the seasonal symptom experience. The treatment course is typically three to five years, with many patients experiencing significant improvement within the first fall season.
Comprehensive Allergen Profiling
Undergo IgE testing to identify all fall weed pollen sensitizations โ Amaranthaceae (kochia, lambsquarters, Russian thistle), ragweed, mugwort, and any other confirmed allergens.
Custom SLIT Formulation
A board-certified allergist creates a personalized sublingual drop formula targeting the allergens contributing most to your symptoms.
Daily Home Treatment
Place drops under your tongue daily. The sublingual mucosa absorbs allergen proteins, gradually retraining immune tolerance.
Long-Term Benefit
After 3-5 years, most patients maintain reduced symptoms and medication requirements even after stopping immunotherapy.
โClinical evidence indicates 60-85% symptom reduction for treated weed pollen allergiesโ
Treat your Burning Bush allergy at the source
See if at-home sublingual allergy drops fit your allergies โ a 2-minute quiz, designed by board-certified allergists, with no needles and no clinic visits.
- MD-ledBoard-certified allergists
- Plan-specificPricing ยท Confirm your quote
- 50K+Patients treated
- HSA/FSAEligible
Living With Burning Bush (Kochia) Allergy
Living with kochia allergy in the Great Plains and western US means accepting a predictable annual pattern: July through October brings weed pollen challenges, and proactive management is more effective than reactive treatment. Knowing your specific sensitization profile โ which Amaranthaceae members and other fall weeds trigger your symptoms โ empowers targeted treatment decisions. For many patients, the disambiguation itself is therapeutic: understanding that your burning bush allergy comes from the weedy kochia, not the ornamental Euonymus, clarifies which plants to avoid and which are harmless.
Know Which Burning Bush Is Yours
Bassia scoparia (kochia) is the allergenic weed โ a fast-growing annual with feathery green foliage that turns red in fall. Euonymus alatus (winged euonymus) is the common ornamental shrub with corky wing-like bark and brilliant red fall leaves โ this one is not allergenic.
Prepare for Fall Proactively
Start nasal corticosteroids in June, stock up on antihistamines, and schedule an allergist visit in spring to review your immunotherapy plan before peak pollen season arrives.
Protect Your Indoor Air
HEPA purifiers and sealed windows during July-October create a meaningful respite from outdoor pollen. Invest in bedroom air quality as your top priority โ quality sleep sustains resilience through allergy season.
Track Herbicide-Resistant Kochia Trends
As herbicide-resistant kochia spreads across the Great Plains, population densities may increase in your area over time. Stay informed about local weed management and discuss any worsening symptoms with your allergist.
When Is Kochia Pollen Season?
Kochia pollen season runs from late summer through fall, typically July through October, with peak production in August and September across most of the Great Plains and western US. This timing coincides precisely with Russian thistle, ragweed, and mugwort seasons, creating a composite fall weed pollen challenge for polysensitized patients. Kochia's ornamental form (Bassia scoparia f. trichophylla), commonly planted in gardens for its dramatic red fall color change, produces the same allergenic pollen as its weedy counterpart. Homeowners with ornamental kochia may have a hyper-local pollen source without realizing it. A practical diagnostic challenge: Chenopodium and Amaranthus pollen grains are morphologically indistinguishable from Bassia pollen under light microscopy. Pollen count reports typically group these under the Chenopodiaceae/Amaranthaceae category rather than identifying Bassia specifically, making it difficult to track kochia-specific pollen levels.
July - August
high intensity
September - October
high intensity
Preventing Kochia Allergy Reactions
Prevention of kochia pollen reactions requires consistent environmental control during the four-month fall pollen season. While complete avoidance is impractical in endemic regions, targeted strategies can meaningfully reduce exposure. For homeowners, removing ornamental kochia (Bassia scoparia f. trichophylla) from your landscaping eliminates a direct pollen source within your immediate living environment.
Remove Ornamental Kochia
If you have ornamental burning bush plants (the feathery annual that turns red in fall โ not the Euonymus shrub), consider replacing them with non-allergenic alternatives to eliminate a home pollen source.
Monitor Fall Pollen Counts
Track local Chenopodiaceae/Amaranthaceae pollen reports from July through October. On high-count days, limit outdoor time and keep windows closed.
Use HEPA Filtration
Run HEPA air purifiers in bedrooms and living spaces during fall pollen season. Replace HVAC filters monthly for maximum pollen removal.
Shower and Change After Outdoor Exposure
Rinse pollen from your hair and skin and change clothes after spending time outdoors during peak kochia pollen periods.
Pre-Medicate Before Fall Season
Begin intranasal corticosteroids two weeks before your fall symptoms typically start to build protective anti-inflammatory effects in the nasal mucosa.
Long-Term Outlook for Kochia Allergy
Kochia allergy is a chronic condition that generally persists throughout adulthood. However, effective treatment options make long-term symptom management highly achievable. Pharmacotherapy controls symptoms during pollen season, and immunotherapy targeting Amaranthaceae weed pollens offers lasting disease modification after 3-5 years of treatment. The expanding prevalence of herbicide-resistant kochia may increase population exposure over coming decades, making early diagnosis and treatment particularly important for patients in affected regions.
Key takeaways
Burning bush allergy refers to kochia (Bassia scoparia), not the ornamental shrub Euonymus alatus โ disambiguation is essential.
Kochia has research-characterized allergens (Koc s 1, Koc s 2) that are not yet IUIS-listed, representing a gap between clinical significance and formal allergen database inclusion.
Extensive Amaranthaceae cross-reactivity means kochia-sensitized patients frequently also react to lambsquarters, Russian thistle, and pigweed.
Immunotherapy targeting fall weed pollens provides the best long-term disease control for patients in endemic regions.
Diet and Kochia Allergy
Kochia pollen allergy is not associated with significant food cross-reactivity syndromes. Despite Koc s 1 sharing structural homology with Ole e 1 (olive), there is no documented clinical cross-reactivity between kochia pollen and olive fruit or oil consumption. General anti-inflammatory dietary strategies may provide modest supplementary benefit during the fall allergy season.
Foods that help
Omega-3-rich fish
Anti-inflammatory fatty acids may help modulate baseline airway inflammation during fall pollen season.
Green tea
Contains epigallocatechin gallate (EGCG), which has demonstrated mast cell-stabilizing properties in laboratory studies.
Kochia is the allergenic burning bush โ not the ornamental Euonymus in your yard. Patients who identify kochia as their trigger should start intranasal corticosteroids by mid-June and expect fall weed immunotherapy to address the entire Amaranthaceae network, not just kochia alone.
Frequently Asked Questions
No. The allergenic burning bush is Bassia scoparia (kochia), a wind-pollinated annual weed in the Amaranthaceae family. The common ornamental burning bush is Euonymus alatus (winged euonymus), an insect-pollinated shrub in the Celastraceae family with no significant allergenicity. They are completely unrelated plants from different families. If you have Euonymus alatus in your yard, it is not causing your allergy symptoms. In practice, most allergists treat both species together when prescribing kochia extract immunotherapy. The two plants share only the common name โ when speaking with your allergist, always specify Bassia scoparia (kochia) as the weed causing your symptoms, not the ornamental Euonymus.
Medical References
- [1]Villalba M, Barderas R, Mas S, et al. Amaranthaceae pollens: Review of an emerging allergy in the Mediterranean area. J Investig Allergol Clin Immunol. 2014;24(6):371-381.
- [2]Bousquet J, Heinzerling L, Bachert C, et al. Practical guide to skin prick tests in allergy to aeroallergens. Allergy. 2012;67(1):18-24.
- [3]AAAAI/ACAAI Joint Task Force on Practice Parameters. Allergen immunotherapy: a practice parameter third update. J Allergy Clin Immunol. 2011;127(1 Suppl):S1-55.
- [4]Larenas-Linnemann D, Michels A, Ackermann-Simon J, et al. Allergen sensitization linked to climate change in the United States. Ann Allergy Asthma Immunol. 2020;125(3):258-268.
- [5]Sander I, Flagge A, Merget R, et al. Identification of grass pollen allergens by means of immunoblotting. Int Arch Allergy Immunol. 2001;124(1-3):31-34.
- [6]Durham SR, Walker SM, Varga EM, et al. Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med. 1999;341(7):468-475.
- [7]Tharpe C, et al. Real-world outcomes of personalized sublingual immunotherapy for environmental allergies delivered through a telemedicine platform. Frontiers in Allergy. 2026;7:1865860.
- [8]Schaffer FM, Naples AR, Ebeling M, Hulsey TC, Garner LM. The safety of self-administered allergen immunotherapy during the buildup and maintenance phases. Int Forum Allergy Rhinol. 2015;5(2):149-156.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.
Ready to treat your Burning Bush allergies for good?
Get a personalized treatment plan from board-certified allergists, delivered to your door.
Reviewed by board-certified allergists. Personalized treatment plans based on your at-home IgE test, not generic protocols.
Compare Curex plan pricingQuestions about Curex itself?
Straight answers about the company, the evidence, what patients report, and what it costs โ including the parts that are not flattering.

